Skip to main content
Clinical Trials/NCT04800913
NCT04800913
Recruiting
Not Applicable

The Role of Multimodality Imaging in Left Atrial Appendage Closure

Hungarian Institute of Cardiology1 site in 1 country44 target enrollmentNovember 8, 2021

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Atrial Fibrillation
Sponsor
Hungarian Institute of Cardiology
Enrollment
44
Locations
1
Primary Endpoint
Effective radiation dose
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

The aim of the present prospective, randomized single-centre study is to examine the success rate, safety, overall preoperative and operative burden and long-time outcome of percutaneous left atrial appendage closure procedures after unimodal and multimodal preprocedural imaging.

According to the investigators' primary hypothesis, simple, unimodal preprocedural imaging does not increase procedural burden of LAAC (total radiation dose, procedure time, fluoroscopy time, contrast amount). The investigators assume, that the success rate and safety of LAAC procedures is not reduced using unimodal preoperative imaging.

Regarding to postoperative imaging, the investigators aim to compare the sensitivity of different imaging techniques in detecting postoperative complications. We assume, that multimodal imaging technique increases the accuracy and sensitivity of the detection of postoperative complications (PDL, device thrombi).

Detailed Description

Left atrial appendage closure (LAAC) is an increasingly used non-pharmacologic strategy to prevent stroke in patients with atrial fibrillation who have absolute or relative contraindications to long-term oral anticoagulant therapy, mainly due to previous major bleeding or high bleeding risk. As the majority of candidates are elderly patients with multiple morbidities, the reduction of procedural burden is of huge significance. The aim of the present prospective, randomized, single-centre study is to examine the non-inferiority of unimodal (MDCT) vs. multimodal (MDCT+TOE) preprocedural imaging in percutaneous left atrial appendage closure. The investigators are going to assess the success rate, safety and complications of LAAC procedures, and determine the procedural burden (total radiation dose, procedure time, fluoroscopy time, contrast amount) of the interventions after preprocedural unimodal and multimodal appendage characterization and device sizing. Multimodal procedural guidance (2D/3D TOE, fluoroscopy-angiography) and multimodal postprocedural imaging (2D/3D TOE, MDCT) is going to be used to identify complications (peri-device leak, thrombus). The investigators are planning to compare the accuracy and additive value of different postoperative imaging techniques. .

Registry
clinicaltrials.gov
Start Date
November 8, 2021
End Date
December 1, 2029
Last Updated
last year
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Hungarian Institute of Cardiology
Responsible Party
Principal Investigator
Principal Investigator

Anita Zadori MD, PhD

cardiologist, Hungarian Institute of Cardiology (Gottsegen National Cardiovascular Center)

Hungarian Institute of Cardiology

Eligibility Criteria

Inclusion Criteria

  • Patients, who have clinical indication to LAAC and are undergoing percutaneous LAAC procedure in Gottsegen National Cardiovascular Center from 10.03.2021 to 31.12.2025
  • Age above 18 years
  • Informed consent
  • Legal capacity

Exclusion Criteria

  • Age under 18 years
  • Pregnancy
  • Incapacitation
  • Absence of consent
  • Esophageal stenosis or diverticulum
  • Active esophageal bleeding
  • CT-contrast agent allergy
  • Severe chronic kidney disease (GFR\<15 ml/min/1,73 m2)
  • Appendage thrombus (mobile/with significant embolic risk)
  • Life expectancy shorter than 12 months

Outcomes

Primary Outcomes

Effective radiation dose

Time Frame: Periprocedural (1 month) interval

Total radiation dose of the patient resorbed during LAAC imaging and intervention (mSv)

Secondary Outcomes

  • Rate of successful implantations(during the procedure)
  • Procedure time(during the procedure)
  • Rate of clinical events(2 years post-procedure)
  • Contrast media amount(during the procedure)
  • Rate of patients with adequate seal of closure device(6 weeks post-procedure)
  • Rate of procedural complications(within 30 days post-procedure)
  • Fluoroscopy time(during the procedure)

Study Sites (1)

Loading locations...

Similar Trials